Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;37(2):e16.
doi: 10.1093/nar/gkn991. Epub 2008 Dec 12.

DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways

Affiliations

DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways

Zengyi Shao et al. Nucleic Acids Res. 2009 Feb.

Abstract

The assembly of large recombinant DNA encoding a whole biochemical pathway or genome represents a significant challenge. Here, we report a new method, DNA assembler, which allows the assembly of an entire biochemical pathway in a single step via in vivo homologous recombination in Saccharomyces cerevisiae. We show that DNA assembler can rapidly assemble a functional D-xylose utilization pathway (approximately 9 kb DNA consisting of three genes), a functional zeaxanthin biosynthesis pathway (approximately 11 kb DNA consisting of five genes) and a functional combined D-xylose utilization and zeaxanthin biosynthesis pathway (approximately 19 kb consisting of eight genes) with high efficiencies (70-100%) either on a plasmid or on a yeast chromosome. As this new method only requires simple DNA preparation and one-step yeast transformation, it represents a powerful tool in the construction of biochemical pathways for synthetic biology, metabolic engineering and functional genomics studies.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Construction of the d-xylose utilization pathway in Saccharomyces cerevisiae. (a) The assembled d-xylose utilization pathway with its corresponding verification primers; (b) PCR analysis of the assembled d-xylose utilization pathway on a plasmid [d-xylose utilization (p), using pRS426m as a backbone] and on a chromosome [d-xylose utilization (c), integrated to the δ site(s)]. M represents 1 kb DNA ladder from Invitrogen; (c) Growth of S. cerevisiae strains carrying d-xylose utilization pathway using d-xylose as the sole carbon source. Cells carrying the empty vector pRS426 were used as the negative control.
Figure 2.
Figure 2.
Construction of the zeaxanthin biosynthesis pathway in Saccharomyces cerevisiae. (a) The assembled zeaxanthin biosynthesis pathway with its corresponding verification primers; (b) PCR analysis of the assembled zeaxanthin biosynthesis pathway on a plasmid [zeaxanthin biosynthesis (p), using pRS426m as a backbone] and on a chromosome [zeaxanthin biosynthesis (c), integrated to the δ site(s)]. M represents 1 kb DNA ladder from Invitrogen; (c) HPLC analysis of the cell extracts from S. cerevisiae carrying the zeaxanthin biosynthesis pathway. Cells carrying the empty vector pRS426 were used as the negative control.
Figure 3.
Figure 3.
Construction of the combined d-xylose utilization and zeaxanthin biosynthesis pathway in Saccharomyces cerevisiae. (a) The assembled combined d-xylose utilization and zeaxanthin biosynthesis pathway with its corresponding verification primers; (b) PCR analysis of the assembled combined d-xylose utilization and zeaxanthin biosynthesis pathway on a plasmid [combined pathway (p), using pRS426m as a backbone] and on a chromosome [combined pathway (c), integrated to the δ site(s)]. M represents 1 kb DNA ladder from Invitrogen; (c) Growth of S. cerevisiae strains carrying the combined pathway using d-xylose as the sole carbon source; (d) HPLC analysis of the cell extracts from S. cerevisiae carrying the combined pathway. Cells carrying the empty vector pRS426 were used as the negative control.
Figure 4.
Figure 4.
Physical characterization of the recombinant clones using pRS416m as a backbone through restriction digestion. Plasmids corresponding to the clones from the eight-gene pathway with ∼50 bp, ∼125 bp and 270–430 bp overlaps were digested by BamHI and EcoRI. The correct clones should exhibit five bands with sizes of 2233, 2551, 3218, 4454 and 11 386 bp.
Scheme 1.
Scheme 1.
A one-step method for assembly and integration of a biochemical pathway using in vivo homologous recombination in S. cerevisiae. (a) One-step assembly into a vector. (b) One-step integration to a δ site on a S. cerevisiae chromosome. n represents the number of DNA fragments.

References

    1. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature. 2006;440:940–943. - PubMed
    1. Dejong JM, Liu Y, Bollon AP, Long RM, Jennewein S, Williams D, Croteau RB. Genetic engineering of taxol biosynthetic genes in Saccharomyces cerevisiae. Biotechnol. Bioeng. 2006;93:212–224. - PubMed
    1. Szczebara FM, Chandelier C, Villeret C, Masurel A, Bourot S, Duport C, Blanchard S, Groisillier A, Testet E, Costaglioli P, et al. Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat. Biotechnol. 2003;21:143–149. - PubMed
    1. Yan Y, Kohli A, Koffas MA. Biosynthesis of natural flavanones in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2005;71:5610–5613. - PMC - PubMed
    1. Chang MC, Keasling JD. Production of isoprenoid pharmaceuticals by engineered microbes. Nat. Chem. Biol. 2006;2:674–681. - PubMed

Publication types